Loss of the tumor-suppressor genes PTEN, RB1, and TP53 was correlated with increased androgen receptor (AR) expression, BRCA2 gene loss, and gains in chromosomal regions where PTK2, MYC, and NCOA2 genes are localized [85]. The gene discussed is MYC; the disease is neoplasm.